Proveris Scientific has announced the launch of a new collection system called Kinaero Cx that is designed for improved sample collection consistency during MDI testing. The new system, which includes the company’s Vereo automated actuator technology, controls parameters for inhaler shaking and actuation, shake-to-fire timing, and flow rate and can be used for both delivered dose uniformity (DDU) and aerodynamic particle size distribution (APSD) testing. The company said that it will be demonstrating the system during its workshop at RDD 2022.
According to Proveris, the Kinaero Cx offers easy switching between a DDU set up and an Andersen or NGI cascade impactor, and the availability of various device holder inserts also allow users to switch quickly between different inhaler types. The new system also uses the same software platform as the company’s Kinaero high throughput fire down system.
Proveris Scientific Senior Product Manager Ian Flaherty said, “An aim for the product design team at Proveris is the evolution of our product portfolio to allow customers to meet complex regulatory requirements and produce consistent high quality data. Our 25-plus years of experience in the OINDP space has taught us much about the potential for automation in reducing the variability associated with inhaler testing. The Kinaero Cx takes these learnings a step further and is designed to be an accessory to our very well-known Vereo Actuator, providing another layer of automation to benefit our customers. The solution is elegant and easy to use, and the powerful software platform will meet our customer’s strict demands for ensuring data integrity and traceability.”
Read the Proveris Scientific press release.
